Microbiome Therapeutics Market to reach USD 1782.9 million by 2032, and grow at a CAGR of 31.1%
Growing research and development activities, increasing prevalence of chronic diseases, and rising awareness regarding the significance of gut health are some of the major factors impelling the microbiome therapeutics market growth. U.S. National Institutes of Health (NIH), which has spent more than $1.7 billion on the Human Microbiome Project alone since the initiative began in 2007.